Anti-Xa Monitoring Interpreter

Samples must be processed quickly. Residual platelets in the plasma can release Platelet Factor 4 (PF4), which neutralizes heparin and falsely lowers the Anti-Xa result.

In patients with high Factor VIII or Fibrinogen (acute phase reactants), the aPTT may be "artificially" short, making the patient appear heparin-resistant. The Anti-Xa assay is independent of these factors and provides a more accurate measure of the actual anticoagulant effect.

The Anti-Xa assay measures the ability of heparin-antithrombin complexes to inhibit a known amount of Factor Xa, providing a direct measurement of "biological activity" rather than a "clotting time" proxy.